In today’s complex, outsourced pharmaceutical manufacturing landscape, choosing the right external partners can make or break your development timelines, budget, and ultimately your product’s success.
CDMO Live 2025 (7-8 May, Rotterdam) is Europe’s must-attend event for external manufacturing decision makers. It offers an unparalleled opportunity to future-proof your manufacturing strategy through targeted networking and practical knowledge sharing.
Enter your information below to download a PDF of our Convince Your Manager letter template:
While many conferences promise networking, CDMO Live delivers measurable ROI through its innovative and highly efficient PartnerMatch programme.
Meet 50+ curated CDMOs in just two days through pre-scheduled meetings – equivalent to months of separate site visits and calls, saving significant travel costs and time away from the office. There will also be a Site Tour with HALIX advanced biologics facility.
Gain exclusive insights from senior executives at AstraZeneca, MSD, J&J, BMS, Novartis, Daiichi Sankyo, and Boehringer Ingelheim who face the same challenges you do.
Participate in Outsourcing Excellence roundtables covering critical topics like tech transfer optimisation. Digital integration across CDMOs, innovative contract models, supply chain security and real-world quality management.
The event caters to different functional roles across external manufacturing:
With team discounts available, sending multiple colleagues delivers exceptional value as you can divide and conquer the programme’s concurrent sessions.
The ticket price includes:
Download our ready-to-use manager approval letter that outlines all key benefits, speaker highlights, and expected ROI to make requesting approval straightforward.
Don’t delay in securing your team’s places at this must-attend event for anyone involved in external manufacturing decisions.
Enter your information below to download a PDF of our Convince Your Manager letter template:
Help us find the most innovative and trusted suppliers in Pharma and Biotech.